Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Statistics

Total Valuation

Ajooni Biotech has a market cap or net worth of INR 850.88 million. The enterprise value is 952.27 million.

Market Cap	850.88M
Enterprise Value	952.27M

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Ajooni Biotech has 172.24 million shares outstanding. The number of shares has decreased by -51.30% in one year.

Current Share Class	172.24M
Shares Outstanding	172.24M
Shares Change (YoY)	-51.30%
Shares Change (QoQ)	+41.44%
Owned by Insiders (%)	17.59%
Owned by Institutions (%)	n/a
Float	129.84M

Valuation Ratios

The trailing PE ratio is 10.34.

PE Ratio	10.34
Forward PE	n/a
PS Ratio	0.56
PB Ratio	0.93
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	19.36
EV / Sales	0.63
EV / EBITDA	13.24
EV / EBIT	16.05
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.11.

Current Ratio	3.20
Quick Ratio	1.06
Debt / Equity	0.11
Debt / EBITDA	1.43
Debt / FCF	n/a
Interest Coverage	36.54

Financial Efficiency

Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is 4.84%.

Return on Equity (ROE)	5.51%
Return on Assets (ROA)	3.58%
Return on Invested Capital (ROIC)	4.84%
Return on Capital Employed (ROCE)	6.39%
Weighted Average Cost of Capital (WACC)	5.36%
Revenue Per Employee	11.36M
Profits Per Employee	367,067
Employee Count	134
Asset Turnover	1.47
Inventory Turnover	5.30

Taxes

In the past 12 months, Ajooni Biotech has paid 16.11 million in taxes.

Income Tax	16.11M
Effective Tax Rate	24.68%

Stock Price Statistics

The stock price has decreased by -28.16% in the last 52 weeks. The beta is 0.29, so Ajooni Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-28.16%
50-Day Moving Average	4.35
200-Day Moving Average	5.16
Relative Strength Index (RSI)	61.45
Average Volume (20 Days)	820,996

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajooni Biotech had revenue of INR 1.52 billion and earned 49.19 million in profits. Earnings per share was 0.48.

Revenue	1.52B
Gross Profit	307.30M
Operating Income	59.33M
Pretax Income	65.30M
Net Income	49.19M
EBITDA	71.91M
EBIT	59.33M
Earnings Per Share (EPS)	0.48

Balance Sheet

The company has 1.73 million in cash and 103.12 million in debt, with a net cash position of -101.39 million or -0.59 per share.

Cash & Cash Equivalents	1.73M
Total Debt	103.12M
Net Cash	-101.39M
Net Cash Per Share	-0.59
Equity (Book Value)	910.85M
Book Value Per Share	5.53
Working Capital	458.52M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 20.19%, with operating and profit margins of 3.90% and 3.23%.

Gross Margin	20.19%
Operating Margin	3.90%
Pretax Margin	4.29%
Profit Margin	3.23%
EBITDA Margin	4.72%
EBIT Margin	3.90%
FCF Margin	n/a

Dividends & Yields

Ajooni Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	51.30%
Shareholder Yield	51.30%
Earnings Yield	5.78%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2022. It was a forward split with a ratio of 5.

Last Split Date	Oct 7, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5